In connection with the European Immunization Week, ECDC releases data indicating an increase in cases of vaccine-preventable diseases such as measles and pertussis, after decreased levels during the COVID-19 pandemic.
European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the European Immunization Week campaign lead by WHO/Europe by providing scientific evidence on immunisation.
Rubella is a viral infection transmitted from person to person by droplets via coughs and sneezes. In healthy individuals it is usually a mild disease. Up to 50 % of individuals infected with rubella may not show symptoms. However, if a woman gets rubella shortly before getting pregnant or during the first three months of pregnancy, it is very likely to result in miscarriage or congenital anomalies known as congenital rubella syndrome (CRS).
On 23 November WHO Europe published the results from the 5th annual meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC).
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.